openPR Logo
Press release

Cell and Gene Therapy Bioassay Services Market Current Scenario with Future Trends Analysis to 2031

06-07-2024 10:05 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Insightace analytic

Cell and Gene Therapy Bioassay Services Market Current Scenario

InsightAce Analytic announces the release of a market assessment report on the "Global Cell and Gene Therapy Bioassay Services Market- by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological, Infectious, Autoimmune, Rare/Genetic, Cardiovascular, Metabolic, Blood, Neurological, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

The Cell and Gene Therapy Bioassay Services Market Size is valued at 1.84 Billion in 2022 and is predicted to reach 5.64 Billion by the year 2030 at a 15.3 % CAGR during the forecast period for 2023-2030.

Get A Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1208

Cell and gene therapies entail the removal of protein, cells, or genetic material from a patient or donor and modifying the material to provide a highly personalized or targeted treatment. These medications can address complex and uncommon diseases while offering longer-term benefits than conventional treatments. Consequently, the necessity for various contract research organizations that provide bioassay services for cell and gene therapies has increased over time. Various factors, including the increasing demand for sophisticated medical treatments, the increasing prevalence of cancer and other chronic diseases, and the advancements in genomics technology methodologies predominantly drive the market expansion.

Over the forecast period, the demand for bioassay services is anticipated to be driven by the expansion of government investment in the research and development of new cell and gene therapies and the growing demand for personalized medicines. Contract research organizations (CROs) have expanded their bioassay services in response to the increasing demand for cost-effective and efficient cell and gene therapies, which will generate market development potential shortly. Numerous contract research firms have emerged, asserting that they offer bioassay services for cell and gene therapies as the demand for outsourcing bioanalytical services increases.

Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1208

Nevertheless, the global cell and gene therapy bioassay services market's expansion in the coming years may be constrained by the exorbitant cost of bioassay services. Due to the growing number of cell and gene therapy product launches and the increased R&D activity in biopharma businesses to develop cell and gene treatments, North America is expected to be the primary contributor to the Cell and Gene Therapy Bioassay Services Market. Furthermore, the Asia Pacific regional market is anticipated to experience substantial development due to the growing older population, the high prevalence of chronic diseases and genetic abnormalities, the growing demand for personalized treatments, and technological advancements.

Major market players operating in the Cell and Gene Therapy Bioassay Services Market include AnaBioTec (Belgium), CCRM (Canada), Nexelis (Canada), Pacific BioLabs (US), PPD Laboratories (North Carolina), Intertek Pharmaceutical Services (UK), Lonza (Switzerland), Porton Biopharma Ltd (UK), WuXi Advanced Therapies (US), Avomeen (US), Charles River Laboratories (US), Absorption Systems (US), BioAgilytix Labs (US), Catalent, Inc (US), Svar Life Science AB (Sweden), and others.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1208

Recent collaborations and agreements in the market:
• In December 2021, Mediphage Bioceuticals, Inc. was acquired by CCRM Enterprises Inc., the company's venture capital subsidiary. The investment by CCRM Enterprises will be used to finance the development and administration of the technology, as well as to gain access to CCRM's scientific and industrial knowledge. Mediphage is currently focused on the development of a non-viral gene therapy platform that will facilitate the development of individualized genetic treatments that are both safe and effective. This platform will also address numerous deficiencies of current viral vector-based technologies.
• In April 2021, AavantiBio (US), In order to facilitate the development and production of AavantiBio's gene therapies, a gene therapy company and Catalent (US), a supplier of drugs, cells, and gene therapies, entered into a partnership.

Market Segments
Global Cell and Gene Therapy Bioassay Services Market, by Scale of Operation, 2022-2030 (Value US$ Mn)
• Discovery
• Preclinical
• Clinical
Global Cell and Gene Therapy Bioassay Services Market, by Type of Therapy, 2022-2030 (Value US$ Mn)
• Cell Therapy
• Gene Therapy
Global Cell and Gene Therapy Bioassay Services Market, by Therapeutic Area, 2022-2030 (Value US$ Mn)
• Oncological
• Infectious
• Autoimmune
• Rare / Genetic
• Cardiovascular
• Metabolic
• Blood
• Neurological
• Ophthalmic Disorders
• Other Therapeutic Areas
Global Cell and Gene Therapy Bioassay Services Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
> To obtain a thorough examination of the global Cell and Gene Therapy Bioassay Services Market's prospective
> To obtain an industry overview and future trends of the Cell and Gene Therapy Bioassay Services Market
> To conduct an analysis of the drivers and challenges of the Cell and Gene Therapy Bioassay Services Market
> To obtain information regarding the Cell and Gene Therapy Bioassay Services Market value (US$ Mn) forecast through 2030
> The Cell and Gene Therapy Bioassay Services Market industry has experienced substantial investments, mergers, and acquisitions.

Details insights on this market: https://www.insightaceanalytic.com/report/global-cell-and-gene-therapy-bioassay-services-market/1208

Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email: info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cell and Gene Therapy Bioassay Services Market Current Scenario with Future Trends Analysis to 2031 here

News-ID: 3530284 • Views:

More Releases from Insightace analytic

Digital Pathology Market Report- Expansive Coverage on the Profit Sources
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031" The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031 "Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by
Digital Diabetes Management Market Report on the Untapped Growth Opportunities in the Industry
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 2031
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031" The Global Data Center Liquid Cooling Market is estimated

All 5 Releases


More Releases for Therapy

Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023. The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market. Factors that are likely to hamper the growth of the market